domingo, 15 de novembro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 12, 2026

How Much Money Does Social Security Generate From Investing? Here's What's Inside the $2.5 Trillion Trust Fund.

View original at nasdaq.com
How Much Money Does Social Security Generate From Investing? Here's What's Inside the $2.5 Trillion Trust Fund. Key Points Social Security is set to deplete its trust fund within the next seven years…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The longer Congress waits to act on Social Security reform, the more severe the changes will have to be

    60% confidence
  • The practical impact on Social Security's impending shortfall from investing in equities is negligible when considering conservative asset allocations and slow ramp up

    60% confidence
  • The income generated from Social Security investments has steadily declined over the last 15 years

    60% confidence
  • Those hoping Social Security can simply invest its way out of the deficit will be sorely disappointed

    60% confidence
  • Social Security is set to deplete its trust fund within the next seven years, before the end of 2032

    60% confidence
  • Congress will need to enact significant reforms affecting tax rates, taxable income, full retirement age, and possibly cost-of-living adjustments to protect Social Security

    60% confidence
  • Even a 100% allocation to equities wouldn't make up the deficit expected for Social Security

    60% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,995
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,995 factos verificados com a fonte5,580 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
How Much Money Does Social Security Generate From Investing? Here's What's Inside the $2.5 Trillion Trust Fund. — Source | Via News | pt.via.news